U.S. Markets closed
  • S&P 500

    3,390.68
    -10.29 (-0.30%)
     
  • Dow 30

    27,463.19
    -222.21 (-0.80%)
     
  • Nasdaq

    11,431.35
    +72.41 (+0.64%)
     
  • Russell 2000

    1,590.71
    -14.50 (-0.90%)
     
  • Crude Oil

    38.86
    -0.71 (-1.79%)
     
  • Gold

    1,908.80
    -3.10 (-0.16%)
     
  • Silver

    24.41
    -0.16 (-0.65%)
     
  • EUR/USD

    1.1780
    -0.0033 (-0.2827%)
     
  • 10-Yr Bond

    0.7780
    -0.0230 (-2.87%)
     
  • Vix

    33.35
    +0.89 (+2.74%)
     
  • GBP/USD

    1.3028
    +0.0007 (+0.0521%)
     
  • USD/JPY

    104.5240
    -0.3110 (-0.2967%)
     
  • BTC-USD

    13,665.03
    +16.52 (+0.12%)
     
  • CMC Crypto 200

    270.32
    +9.03 (+3.46%)
     
  • FTSE 100

    5,728.99
    -63.02 (-1.09%)
     
  • Nikkei 225

    23,485.80
    -8.54 (-0.04%)
     

Celanese's Ethylene-based VAM Awarded Green Technology Tag

Zacks Equity Research

Celanese Corporation CE announced that its ethylene-based Vinyl Acetate Monomer (VAM) technology has been awarded the "Green Technology" designation by China Petroleum and Chemical Industry Federation.

Notably, the designation was awarded to the company’s ethylene-based VAM technology due to its low carbon emissions, low content of heavy components, low energy consumption and high product quality.

Per Management, it will continue  to adhere to its business standards of sustainable product development. It will also work with local governments and associations, and participate actively in related activities to contribute further to China’s green development.

Notably, ethylene-based VAM is used in the production of different types of polymer emulsions, which are base resins for water-based paints, paper coatings, adhesives and textile finishes.

The company’s shares have gained 24.7% in the past year compared with the industry’s 13.6% growth.

 

 

In October 2019, Celanese lowered its adjusted earnings per share guidance for 2019 on expectations of weak market conditions. The company anticipates adjusted earnings of $9.60-$9.80 per share for the year compared with $10.50 mentioned earlier. The revised earnings guidance incorporates the fourth-quarter impact of an earlier announced unplanned outage at Celanese’s Clear Lake facility in Texas.

Notably, the company plans to remain focused on executing productivity programs, enhancing the business model and investing in high-return projects, which it anticipates to deliver double-digit growth in 2020 adjusted earnings per share.

Celanese expects 2020 adjusted earnings of $11-$12 per share. It expects to achieve the same in the higher end of the range if demand condition improves next year.

Celanese Corporation Price and Consensus

 

Celanese Corporation Price and Consensus
Celanese Corporation Price and Consensus

Celanese Corporation price-consensus-chart | Celanese Corporation Quote

Zacks Rank & Stocks to Consider

Celanese currently carries a Zacks Rank #4 (Sell).

Some better-ranked stocks in the basic materials space are Daqo New Energy Corp. DQ, Pan American Silver Corp. PAAS and Sibanye Gold Limited SBGL.

Daqo New Energy has a projected earnings growth rate of 315.4% for 2020. The company’s shares have rallied 130.4% in a year. It sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Pan American Silver has an estimated earnings growth rate of 46.3% for 2020. It currently flaunts a Zacks Rank #1. The company’s shares have gained 47.1% in a year.

Sibanye Gold has a Zacks Rank #2 (Buy) and a projected earnings growth rate of 587.5% for 2020. The company’s shares have soared 235.4% in a year.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Celanese Corporation (CE) : Free Stock Analysis Report
 
DAQO New Energy Corp. (DQ) : Free Stock Analysis Report
 
Sibanye Gold Limited (SBGL) : Free Stock Analysis Report
 
Pan American Silver Corp. (PAAS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research